Hematology NewsNovel options for treating hairy cell leukemiaOctober 2, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaB Cell Lymphoma
Hematology NewsReal-world clues for optimal sequencing of CLL novel agentsSeptember 25, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves new drug for CLL/SLL and follicular lymphomaSeptember 25, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsBe wary of watchful waiting in follicular lymphomaSeptember 16, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsPruritus linked to wide variety of cancersSeptember 16, 2018Indolent LymphomaAMLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationGynecologic CancerB Cell LymphomaB Cell Lymphoma
Oncology PracticeASCO updates guidance on prophylaxis for adults with cancer-related immunosuppressionSeptember 7, 2018Patient & Survivor CareIndolent LymphomaB Cell Lymphoma
Hematology NewsRituximab/lenalidomide similar to rituximab/chemotherapy for follicular lymphomaSeptember 6, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFDA approves ibrutinib with rituximab in Waldenström’s macroglobulinemiaAugust 27, 2018Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsMake The Diagnosis - September 2018August 14, 2018Nonmelanoma Skin CancerRare DiseasesT Cell LymphomasIndolent LymphomaB Cell Lymphoma
Hematology NewsNew chronic lymphocytic leukemia guidelines from the UKAugust 8, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent Lymphoma
Oncology PracticeInsurance is a matter of life or death for lymphoma patientsAugust 6, 2018Practice ManagementLymphoma & Plasma Cell DisordersIndolent LymphomaBusiness of MedicineFollicular Lymphoma
Oncology PracticeLate mortality risk after childhood BMT is substantial, persistentJuly 28, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
Hematology NewsRituximab reduces risk of follicular lymphoma transformationJuly 25, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsCombo treatment under review for Waldenstrom macroglobulinemiaJune 26, 2018Indolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIs CLL chemoimmunotherapy dead? Not yetJune 20, 2018CLLLymphoma & Plasma Cell DisordersIndolent Lymphoma
